|June 20, 2002
Holds AIDS Conference Briefing
A UCSF AIDS Research Institute (ARI) news briefing in
advance of the XIV International AIDS Conference will take place next Tuesday, June 25.
More than 100 UCSF ARI scientists are expected to present research findings at the
international meeting, July 7 to 12 in Barcelona, Spain.
The UCSF ARI briefing will open with a presentation by Richard Feachem, PhD, DSc(Med),
executive director-designate of the Global Fund to Fight AIDS, Tuberculosis and Malaria,
and will include overviews of key issues expected in Barcelona by leading researchers and
short summaries by UCSF scientists about their presentations. An additional conference
room has been reserved for individual interviews with scientists during and after the
briefing. Television crews are welcome to set-up in this room for interviews.
THE UCSF ARI BRIEFING FOR LOCAL MEDIA IS SCHEDULED AS FOLLOWS:
Date: Tuesday, June 25
Time: 1:00 to 4:30 PM
Location: UCSF AIDS Research Institute
74 New Montgomery St., Suite 600
Validated Parking is available at the Hearst Garage (Stevenson Street. between 3rd
& New Montgomery)
UCSF MEDIA BRIEFING: XIV INTERNATIONAL AIDS CONFERENCE 12:30 to 1:00 p.m. Early
Arrival---Sandwiches, refreshments and media packets will be available. 1:00 to 1:05 p.m.
"Introduction" Thomas J. Coates, PhD, executive director of the UCSF AIDS
Research Institute. 1:05 to 1:35 "The Global Fund: Progress and Prospects"
Richard Feachem, PhD, DSc(Med), executive director-designate of the Global Fund to Fight
AIDS, Tuberculosis and Malaria, and director of the UCSF/UCB Institute for Global Health.
The following presentations of UCSF research being reported at the International AIDS
Conference are embargoed until time of presentation in Barcelona.
PREVENTION (1) 1:35 to 1:55
Prevention "Prevalence of Sexually Transmitted Infections Among a U.S. Cohort of
Sexually Active HIV-seropositive (HIV+) Men Who Have Sex With Men (MSM)"-- Thomas J.
Coates, PhD, executive director of the UCSF AIDS Research Institute.
SCIENCE 1:55 to 2:15
Trends in Primary HIV-1 Drug Resistance Among Persons Recently Infected with HIV in San
Francisco" Robert M. Grant, MD, MPH, assistant investigator at the Gladstone
Institute for Virology and Immunology and UCSF assistant professor of medicine. 2:15 to
2:30 Overview: Clinical Science Paul Volberding, MD, professor and vice chair, UCSF
department of medicine, and chief of the Medical Service at the San Francisco Veterans
Affairs Medical Center.
2:30 to 2:50
2002: Successes, Setbacks, and Looming Challenges" Warner Greene, MD, PhD, director
of the Gladstone Institute of Virology and Immunology, and UCSF professor of medicine,
microbiology, and immunology. I
RESEARCH 2:50 to 3:20
"The Women's Global Health Imperative" "Intergenerational Sex Among
Adolescents in Zimbabwe" "Diaphragms Are Well Accepted in Sexually Active
Zimbabwean Women" Nancy Padian, PhD, director of international programs at UCSF's
AIDS Research Institute, and director of the Women's Global Health Imperative.
3:20 to 3:40
Off Increases in Young Gay/Bisexual Men's Risk Behavior in the HAART Era" Susan M.
Kegeles, PhD, associate adjunct professor of medicine at UCSF's Center for AIDS Prevention
3:40 to 4:00
Differences in AIDS Survival Before and After Introduction of HAART (Highly Active
Anti-Retroviral Therapy) in San Francisco: Are All Persons Benefiting Equally?"
Sandra Schwarcz, MD, MPH, director of the San Francisco Department of Public Health's AIDS
Statistics and Epidemiology Section and UCSF assistant adjunct professor of epidemiology
4:00 to 4:20
Socio-economic Status Associated with Higher Rates of Death in the Era of HAART"
Willi McFarland, MD, PhD, co-director of the San Francisco Department of Public Health's
HIV/AIDS Statistics and Epidemiology Unit and UCSF assistant adjunct professor of
epidemiology and biostatistics.
information, to RSVP, or to arrange phone call-in number for the media briefing, please
contact Jeff Sheehy at (415) 597-8165.